Your browser doesn't support javascript.
loading
Cereset Research Standard Operating Procedures for Insomnia: A Randomized, Controlled Clinical Trial.
Tegeler, Catherine L; Munger Clary, Heidi; Shaltout, Hossam A; Simpson, Sean L; Gerdes, Lee; Tegeler, Charles H.
Afiliação
  • Tegeler CL; Department of Neurology, Wake Forest School of Medicine (WFSM), Winston-Salem, NC, USA.
  • Munger Clary H; Department of Neurology, Wake Forest School of Medicine (WFSM), Winston-Salem, NC, USA.
  • Shaltout HA; Hypertension and Vascular Research Center, WFSM, Winston-Salem, NC, USA.
  • Simpson SL; Department of Biostatistics and Data Sciences, WFSM, Winston-Salem, NC, USA.
  • Gerdes L; Brain State Technologies, LLC, Scottsdale, AZ, USA.
  • Tegeler CH; Department of Neurology, Wake Forest School of Medicine (WFSM), Winston-Salem, NC, USA.
Glob Adv Integr Med Health ; 12: 27536130221147475, 2023.
Article em En | MEDLINE | ID: mdl-36816469
Background: Interventions for insomnia that also address autonomic dysfunction are needed. Objective: We evaluate Cereset Research™ Standard Operating Procedures (CR-SOP) in a pilot randomized, controlled trial. CR-SOP is a less operator-dependent, more generalizable innovation of HIRREM®, a noninvasive, closed-loop, allostatic, acoustic stimulation neurotechnology demonstrated to improve insomnia and autonomic function. Methods: Adults with Insomnia Severity Index (ISI) scores of ≥8 were randomized to receive ten sessions of CR-SOP, with tones linked to brainwaves (LB, intervention), or a sham condition of random tones not linked to brainwaves (NL, control). Measures were collected at enrollment and 0-14 days and 4-6 weeks post-allocated intervention. The primary outcome was differential change in ISI from baseline to 4-6 weeks post-intervention. Secondary self-report measures assessed sleep quality65 and behavioral outcomes. Ten-minute recordings of heart rate and blood pressure were collected to analyze autonomic function (heart rate variability [HRV] and baroreflex sensitivity). Results: Of 22 randomized, 20 participants completed the allocated condition. Intention to treat analysis of change from baseline to the 4-6 week outcome demonstrated mean ISI score reduction of 4.69 points among controls (SE 1.40). In the intervention group, there was an additional 2.58 point reduction in ISI score (SE 2.13; total reduction of 7.27, P = .24). Sleep quality and some measures of autonomic function improved significantly among the intervention group compared to control. Conclusions: This pilot study compared use of a standardized, allostatic, acoustic neurotechnology intervention with a sham, active control condition. The magnitude of change in insomnia severity was clinically relevant and similar to the findings in a prior, fully powered trial, but the differential improvement observed was not statistically significant. Significant improvements were demonstrated in sleep quality and some autonomic function measures.
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Glob Adv Integr Med Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Clinical_trials Idioma: En Revista: Glob Adv Integr Med Health Ano de publicação: 2023 Tipo de documento: Article País de afiliação: Estados Unidos